As part of an ongoing series of answers to common questions received by the Basser Center for BRCA, Executive Director Susan Domchek, MD, discusses how BRCA mutations impact men, including which cancers they are at hereditary risk for and recommendations for screening.

As part of an ongoing series of answers to common questions received by the Basser Center for BRCA, Executive Director Susan Domchek, MD, discusses BRCA-related ovarian cancer risk and management options, such as recent research into fallopian tube removal.

As part of an ongoing series of answers to common questions received by the Basser Center for BRCA, Executive Director Susan Domchek, MD, discusses typical guidelines for follow up to a potential recurrence of BRCA-related breast cancer.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses early screening recommendations for young women with BRCA mutations, particularly in terms of breast cancer.

Dr. Domchek: One of our questions is what type of screening options are available to a 25 year old woman who has just been found to have a BRCA1/2 mutation.

In the first in an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses recent advancements in treatment options for BRCA-related cancers, such as drugs like PARP inhibitors.

On June 27, 2018, at Foley Hoag LLC in New York City, the Basser Center for BRCA held a panel discussion on the ins and outs of dating with a BRCA mutation.

On June 27, 2018, at Foley Hoag LLC in New York City, the Basser Center for BRCA held a panel discussion on the ins and outs of dating with a BRCA mutation. Speakers included Danielle McKenna, Genetic Counselor at the Basser Center, Lindsay Hoskins, a Couples and Family therapist in Washington, D.C., and two of our Young Leadership Council members: Suzanne Zuppello, a freelance writer and BRCA mutation carrier, and Lauren Profis, a marketing professional and BRCA mutation carrier.

On June 27, 2018, at Foley Hoag LLC in New York City, the Basser Center for BRCA held a panel discussion on the ins and outs of dating with a BRCA mutation.

The Basser Center's 2018 Breakthroughs and Discoveries Panel brought together some of the world's leading experts in genetic research and hereditary cancer.

The Basser Center's internationally recognized experts in cancer genetics, Susan Domchek, MD, and Katherine Nathanson, MD, are working in collaboration with leading experts in the fields of cancer research and genetics in New York, Los Angeles and Boston to launch the pilot phase of a new, independent research initiative: the BRCA Founder Outreach (BFOR) Study.  Principal Investigators include Dr. Kenneth Offit and Dr. Mark Robson of Memorial Sloan Kettering Cancer Center in New York; Dr. Judy Garber of the Dana Farber Cancer Institute and Dr.